MEMPHIS PHARMACEUTICALS & CHEMICAL INDUSTRIES |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95.25 EGP | +0.80% |
|
+9.32% | +51.89% |
Business Summary
Number of employees: 144
Sales per Business
| EGP in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 551 | 100.0 % | 664 | 100.0 % | +20.42% |
Sales per region
| EGP in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Egypt
100.0
%
| 551 | 100.0 % | 664 | 100.0 % | +20.42% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
Heba Samir
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Chief Tech/Sci/R&D Officer | - | - | |
| Investor Relations Contact | - | - | |
Walid Hassan
HRO | Human Resources Officer | - | - |
Mushira Farouk
AUD | Comptroller/Controller/Auditor | - | - |
| Sales & Marketing | - | - | |
Asim Ibrahim
LAW | General Counsel | - | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | 21-12-19 | |
Miral Darwish
BRD | Director/Board Member | - | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 5,625,000 | 1,687,757 ( 30.00 %) | 0 | 30.00 % |
Company contact information
Memphis Pharmaceutical & Chemical Industries
8 Sawah Street Amyria
11281, Cairo
+
http://www.memphis.com.eg
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +51.89% | 11.17M | |
| +26.08% | 662B | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B |
- Stock Market
- Equities
- MPCI Stock
- Company Memphis Pharmaceuticals & Chemical Industries
